| Nov 25 | Feb 26 | May 26 | Aug 26 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Buy | — | 2 | — | — | — | — | — | — | — | — | — | — |
| Sell | — | — | — | — | — | — | — | — | — | — | — | — |
| total | individual payouts | |
|---|---|---|
| 2028 | ‡‡‡‡ |
|
| 2027 | ‡‡‡‡ |
|
| 2026 | 0.04 |
—
—
—
|
| 2025 | 0.39 |
—
—
—
—
|
| 2024 | 1.52 |
—
—
—
—
|
| 2023 | 1.80 |
—
—
—
—
|
| 2022 | 1.70 |
—
—
—
—
|
| 2021 | 1.22 |
—
—
—
—
|
| 2020 | 0.88 |
—
—
—
—
|
| 2019 | 0.44 |
—
—
|
| 2018 | ‡‡‡ |
|
| 2017 | ‡‡‡ |
|
| 2023 | 2024 | 2025 | Q'26 | |
|---|---|---|---|---|
| Cash | 722.68 | 633.48 | 695.69 | 625.74 |
| Receivables | — | — | — | — |
| Inventory | — | — | — | — |
| Other | — | — | — | — |
| 8,605.44 | 8,453.98 | 7,907.20 | 7,176.70 |
| 2023 | 2024 | 2025 | Q'26 | |
|---|---|---|---|---|
| Payables | 8,808.04 | 9,131.08 | 9,133.61 | 8,185.10 |
| ST’ Debt | — | — | — | — |
| Other | — | — | — | — |
| 10,208.54 | 9,654.24 | 9,133.61 | 8,285.10 |
| 10y | 5y | 3y | |
| Sales | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Cash Flow | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Earnings | ‡‡‡ | ‡‡‡ | ‡‡‡ |
| Book Value | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 144.61 | 137.34 | — | — |
—
|
| ’25 | 162.09 | 157.86 | 152.60 | 161.25 |
633.79
|
| ’24 | 179.19 | 175.06 | 180.76 | 172.48 |
707.50
|
| ’23 | 143.95 | 165.11 | 167.50 | 170.32 |
646.86
|
| ’22 | 95.77 | 101.20 | 116.84 | 134.46 |
448.27
|
| ’21 | 104.78 | 105.85 | 97.45 | 96.80 |
404.88
|
| ’20 | 109.27 | 110.17 | 111.68 | 104.57 |
435.68
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 14.87 | 32.38 | — | — |
—
|
| ’25 | 43.19 | (28.62) | 19.85 | (5.92) |
28.50
|
| ’24 | 2.85 | 55.25 | 55.59 | 10.09 |
123.77
|
| ’23 | 60.80 | 30.75 | 47.42 | 56.66 |
195.63
|
| ’22 | 60.85 | 63.31 | 15.47 | 55.28 |
194.90
|
| ’21 | 11.26 | 100.63 | 112.89 | 13.66 |
238.44
|
| ’20 | 35.79 | 12.53 | 59.27 | 25.55 |
133.14
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 14.29 | 31.52 | — | — |
—
|
| ’25 | 43.05 | (29.35) | 15.83 | (8.77) |
20.76
|
| ’24 | 2.78 | 55.29 | 55.44 | 9.95 |
123.44
|
| ’23 | 60.48 | 30.85 | 47.34 | 56.89 |
195.56
|
| ’22 | 60.58 | 62.89 | 14.63 | 54.68 |
192.79
|
| ’21 | 8.86 | 98.68 | 112.26 | 13.35 |
233.15
|
| ’20 | 35.70 | 9.65 | 61.79 | 23.05 |
130.19
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 0.48 | 0.23 | — | — |
—
|
| ’25 | 0.06 | (2.30) | (2.22) | 0.25 |
(4.21)
|
| ’24 | (0.01) | (2.78) | 0.72 | 0.50 |
(1.56)
|
| ’23 | 0.78 | 0.94 | 0.91 | 0.67 |
3.30
|
| ’22 | 1.42 | 0.78 | 1.16 | 1.32 |
4.39
|
| ’21 | 1.36 | 1.50 | 1.36 | 1.30 |
5.52
|
| ’20 | 0.70 | 0.90 | 1.28 | 1.21 |
4.08
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ‡‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 41.97 | 16.72 | 15.99 | 15.03 | — | — | — |
Low Price
|
| ‡‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 63.84 | 49.04 | 30.94 | 27.07 | — | — | — |
High Price
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 496 | 452 | 451 | 475 | — | — | — |
Employees
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.90 | 1.43 | 1.57 | 1.33 | — | — | — |
Revenue/Emp
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 448.27 | 646.86 | 707.50 | 633.79 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Revenue
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 79.53% | 48.25% | 43.62% | 47.21% | — | — | — |
Gross Margin
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 189.68 | 127.52 | (30.24) | (196.18) | ‡‡‡‡‡ | — | — |
EBT
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 42.31% | 19.71% | (4.27%) | (30.95%) | ‡‡‡ | ‡‡‡ | ‡‡‡ |
EBT Margin
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 140.93 | 100.53 | (47.03) | (138.05) | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Net Income
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 12.33 | 9.67 | 112.78 | 7.44 | — | — | — |
Depreciation
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 14.01 | 21.32 | 23.46 | 20.88 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Revenue/Sh
|
| ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | 4.40 | 3.31 | (1.56) | (4.21) | ‡‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡‡ |
Earnings/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 6.09 | 6.45 | 4.10 | 0.94 | — | — | — |
Cash Flow/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (0.07) | 0.00 | (0.01) | (0.25) | ‡‡‡ | ‡‡‡ | ‡‡‡ |
Capex/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 6.02 | 6.44 | 4.09 | 0.68 | — | — | — |
Free CF/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 38.38 | 41.99 | 40.66 | 37.28 | ‡‡‡‡‡ | — | — |
Book Value/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 32.00 | 30.35 | 30.16 | 30.35 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Shares
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 9.43 | 9.02 | 0.00 | 0.00 | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ |
PE Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 3.16 | 1.40 | 1.11 | 1.03 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
PS Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1.16 | 0.71 | 0.64 | 0.57 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
PB Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 7.07 | 4.45 | 2.20 | 2.14 | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ |
EV/Sales
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 16.44 | 14.73 | 12.59 | 65.40 | — | — | — |
EV/FCF
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 194.90 | 195.63 | 123.77 | 28.50 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
Op' Cash Flow
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (2.11) | (0.07) | (0.33) | (7.73) | — | — | — |
Capex
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 192.79 | 195.56 | 123.44 | 20.76 | — | — | — |
FCF
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (868.50) | (1,603.10) | (1,200.26) | (1,226.41) | — | — | — |
Working Cap'
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 2,061.80 | 1,369.92 | 76.11 | 76.43 | — | — | — |
Total Debt
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1,749.94 | 647.23 | (557.37) | (619.26) | — | — | — |
Net Debt
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1,228.32 | 1,274.28 | 1,226.06 | 1,131.28 | — | — | — |
Sh' Equity
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1.23% | 0.88% | (0.41%) | (1.28%) | ‡‡‡‡‡ | — | — |
ROA
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 3.98% | 4.15% | (2.83%) | (23.95%) | — | — | — |
ROIC
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 10.93% | 8.03% | (3.76%) | (11.71%) | ‡‡‡‡‡ | — | — |
ROE
|
Eagle Bancorp (EGBN), a Mid-Atlantic regional bank with heavy commercial real estate (CRE) exposure, has endured a decade of turbulence including COVID, Fed rate hikes, and the 2023 banking crisis, leading to cratering profitability despite revenue doubling from $313 million in 2016 to $707 million in 2024. Net income swung to a $47 million loss in 2024, with EBT margins collapsing to -4.3% amid NIM compression, deposit outflows, and CRE distress from remote work and higher rates. The stock plunged over 60% from 2022 peaks, trading at deeply discounted 1.1x price-to-sales and 0.64x price-to-book ratios, signaling potential undervaluation but underscoring investor fears over asset quality and sector sentiment.
Bright spots include resilient operating cash flow ($4-7 per share), aggressive deleveraging (debt down 96% to $76 million), and insider buying by executives totaling over $126,000 in 2025 with no sales—a bullish signal amid beaten-down peers. Analyst forecasts project a profitability inflection: break-even net income in 2025, rebounding to $78 million in 2027 (EPS $2.55), with ROE recovering to 6.3% as rate cuts ease pressures.
Yet downside risks loom large in sticky deposit costs, CRE delinquencies (40% portfolio concentration vs. 25% industry average), and macro wildcards like elections or Basel III rules. While macro tailwinds could drive 20-30% upside over 12-18 months, balance sheet vigilance and Q1 2026 earnings will be pivotal for any turnaround. Read the full analysis for detailed metrics and risk scenarios.
Keep track of companies that you follow and research.
Full access to our data with predictions and indicators that we calculate daily.
Full access to our screener with tons of custom values and customizable email notifications.
Excel export of financials and screeners you define and save.